CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-22 | HIMES VAUGHN B Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2024-01-22 | Wan Jerry Principal Accounting Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +24,500 | 24,500 | ||
| 2024-01-22 | Wan Jerry Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2024-01-22 | Stewart Richard Alistair Executive Chairman | Grant or award · Performance Restricted Stock Unit (PRSU) | +140,000 | 140,000 | ||
| 2024-01-22 | Stewart Richard Alistair Executive Chairman | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-01-22 | JACOBS CINDY President & CMO | Grant or award · Performance Restricted Stock Unit (PRSU) | +84,000 | 84,000 | ||
| 2024-01-22 | JACOBS CINDY President & CMO | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2024-01-22 | Bencich John CEO | Grant or award · Performance Restricted Stock Unit (PRSU) | +175,000 | 175,000 | ||
| 2024-01-22 | Bencich John CEO | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2023-06-07 | Martell Bridget A Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2023-06-07 | HIMES VAUGHN B Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2023-05-30 | Bencich John CEO | Purchase | +5,000 | $5.50 | $28K | 66,730 |
| 2023-04-28 | Wan Jerry Principal Accounting Officer | Option exercise | +1,250 | 7,101 | ||
| 2023-04-28 | Wan Jerry Principal Accounting Officer | Shares withheld for taxes | −669 | $8.29 | $6K | 6,432 |
| 2023-04-28 | Wan Jerry Principal Accounting Officer | Option exercise · Performance Restricted Stock Unit (PRSU) | −1,250 | 0 | ||
| 2023-04-28 | JACOBS CINDY President & CMO | Option exercise | +2,500 | 18,870 | ||
| 2023-04-28 | JACOBS CINDY President & CMO | Shares withheld for taxes | −609 | $8.29 | $5K | 18,261 |
| 2023-04-28 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | −2,500 | 0 | ||
| 2023-04-28 | Bencich John CEO | Option exercise | +7,500 | 63,557 | ||
| 2023-04-28 | Bencich John CEO | Shares withheld for taxes | −1,827 | $8.29 | $15K | 61,730 |
Page 6 of 36 · 715 trades